Financials PT Industri Jamu dan Farmasi Sido Muncul Tbk

Equities

End-of-day quote INDONESIA S.E. Other stock markets 2025-06-19			5-day change	1st Jan Change
492.00 ^IDR	-1.60%		-4.47%	-16.61%

May. 02	PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
Mar. 19	HSBC Upgrades Industri Jamu Dan Farmasi Sido Muncul to Buy from Hold; Price Target is 675 Rupiah	MT

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	3,335	4,021	3,866	3,566	3,919	3,960	4,405	4,672
Change	-	20.55%	-3.87%	-7.75%	9.9%	1.04%	11.24%	6.05%
EBITDA ¹	1,243	1,654	1,470	1,347	1,580	1,505	1,698	1,765
Change	-	33.1%	-11.12%	-8.35%	17.27%	-4.76%	12.83%	3.95%
EBIT ¹	1,146	1,560	1,375	1,244	1,474	1,399	1,618	1,698
Change	-	36.15%	-11.88%	-9.53%	18.52%	-5.12%	15.72%	4.91%
Interest Paid ²	-522	-862	-780	-681	-832	-1,000	-1,000	-1,000
Earnings before Tax (EBT) ¹	1,200	1,613	1,420	1,220	1,510	1,514	1,690	1,790
Change	-	34.49%	-11.99%	-14.11%	23.83%	0.24%	11.65%	5.92%
Net income ¹	934	1,261	1,105	950.6	1,171	1,102	1,308	1,394
Change	-	35%	-12.39%	-13.95%	23.18%	-5.87%	18.66%	6.57%
Announcement Date	2/8/21	2/7/22	2/10/23	2/19/24	3/6/25	-	-	-

¹IDR in Billions²IDR in Million

Estimates

Fiscal Period: December	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales ¹	-	797.6	1,078	793.4	861.4	1,122	1,245	880.5	731.6	1,002	1,252	907.3	746.5	707.5	1,205	1,053	843.1	730.2	1,292	789.1	886.6	767.9	1,359	1,185	948.2	821.3	1,454
Change	-	-	35.18%	-26.41%	8.57%	30.21%	10.96%	-29.25%	-16.91%	36.91%	24.97%	-27.52%	-17.72%	-5.22%	70.26%	-12.55%	-19.97%	-13.39%	76.99%	-38.94%	12.35%	-13.39%	77%	-12.82%	-19.97%	-13.39%	77%
EBITDA	-	298.9	392.4	-	-	-	-	-	-	-	-	-	-	-	-	517.5	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	31.29%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT ¹	-	275	368.3	-	289.8	457.8	498.2	354.1	185.2	342.4	493	362.3	210.1	165.2	506.1	491.6	260.3	216.9	505.3	-	269.6	208.8	512.4	536.7	292.6	229	551.1
Change	-	-	33.91%	-	-	57.96%	8.83%	-28.91%	-47.7%	84.83%	43.99%	-26.5%	-42.01%	-21.35%	206.28%	-2.85%	-47.06%	-16.66%	132.96%	-	-	-22.55%	145.4%	4.72%	-45.47%	-21.76%	140.68%
Charge d'intérêts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	464.6	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net income	182.3	-	293.2	-	233	-	-	-	150.6	-	-	-	-	-	364.1	390.5	218	169.6	392.9	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7.26%	-44.17%	-22.19%	131.63%	-	-	-	-	-	-	-	-
Announcement Date	7/21/20	10/19/20	2/8/21	4/25/21	7/27/21	10/18/21	2/7/22	4/22/22	7/29/22	10/26/22	2/10/23	4/28/23	7/26/23	10/30/23	2/19/24	4/25/24	7/24/24	10/24/24	3/6/25	5/2/25	-	-	-	-	-	-	-

¹IDR in Billions

Estimates

¹IDR in Billions

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	-1,025	-1,080	-923	-821	-856	-875	-1,071	-952
Change	-	-5.37%	14.54%	11.05%	-4.26%	-2.27%	-22.4%	11.11%
Announcement Date	2/8/21	2/7/22	2/10/23	2/19/24	3/6/25	-	-	-

¹IDR in Billions

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	95.14	122.6	178.4	50.39	45.74	166	128.8	126.3
Change	-	28.81%	45.57%	-71.76%	-9.22%	262.82%	-22.36%	-2.01%
Free Cash Flow (FCF) ¹	940,615	1,076,764	928,734	1,005,007	1,105,190	1,076,000	1,178,600	1,166,667
Change	-	14.47%	-13.75%	8.21%	9.97%	-2.64%	9.54%	-1.01%
Announcement Date	2/8/21	2/7/22	2/10/23	2/19/24	3/6/25	-	-	-

¹IDR in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	37.26%	41.13%	38.03%	37.79%	40.32%	38%	38.54%	37.78%
EBIT Margin (%)	34.35%	38.8%	35.56%	34.88%	37.61%	35.32%	36.74%	36.34%
EBT Margin (%)	35.96%	40.12%	36.73%	34.2%	38.53%	38.23%	38.37%	38.32%
Net margin (%)	28%	31.36%	28.58%	26.66%	29.88%	27.84%	29.69%	29.84%
FCF margin (%)	28,200.87%	26,778.65%	24,026.09%	28,183.59%	28,200.21%	27,171.52%	26,755.42%	24,973.93%
FCF / Net Income (%)	100,706.52%	85,396.6%	84,070.09%	105,718.1%	94,377.92%	97,611.13%	90,104.41%	83,692.01%
Profitability
ROA	25.32%	31.85%	27.11%	23.85%	29.91%	27.93%	31.79%	33.67%
ROE	29.72%	37.68%	31.67%	27.59%	34.07%	31.77%	33.89%	34.51%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	2.85%	3.05%	4.62%	1.41%	1.17%	4.19%	2.92%	2.7%
CAPEX / EBITDA (%)	7.66%	7.41%	12.14%	3.74%	2.89%	11.03%	7.59%	7.15%
CAPEX / FCF (%)	0.01%	0.01%	0.02%	0.01%	0%	0.02%	0.01%	0.01%
Items per share
Cash flow per share ¹	34.53	40.21	36.9	35.18	38.36	40.31	41.16	41.8
Change	-	16.45%	-8.22%	-4.67%	9.05%	5.07%	2.11%	1.55%
Dividend per Share ¹	31.16	34.2	-	-	-	34.8	37.84	40.53
Change	-	9.75%	-	-	-	-	8.73%	7.11%
Book Value Per Share ¹	107.4	115.7	116.8	112.9	116.3	118.8	126	128.9
Change	-	7.75%	0.97%	-3.41%	3.01%	2.17%	6.12%	2.29%
EPS ¹	31.14	42.28	36.82	31.69	39.03	37.18	43.11	45.47
Change	-	35.76%	-12.91%	-13.93%	23.16%	-4.73%	15.94%	5.48%
Nbr of stocks (in thousands)	29,995,964	29,997,475	30,000,000	30,000,000	30,000,000	29,985,950	29,985,950	29,985,950
Announcement Date	2/8/21	2/7/22	2/10/23	2/19/24	3/6/25	-	-	-